|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM237970813 |
| 003 |
DE-627 |
| 005 |
20250217001054.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2014 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1111/vcp.12149
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n0793.xml
|
| 035 |
|
|
|a (DE-627)NLM237970813
|
| 035 |
|
|
|a (NLM)24798181
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Criswell, Kay A
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Comparison of the Sysmex XT-2000iV and microscopic bone marrow differential counts in Wistar rats treated with cyclophosphamide, erythropoietin, or serial phlebotomy
|
| 264 |
|
1 |
|c 2014
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 16.04.2015
|
| 500 |
|
|
|a Date Revised 20.10.2016
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2014 American Society for Veterinary Clinical Pathology and European Society for Veterinary Clinical Pathology.
|
| 520 |
|
|
|a BACKGROUND: In a previous study, it was demonstrated that bone marrow analysis using the Sysmex XT-2000iV hematology analyzer produced differential counts in untreated rats that were comparable to microscopic differential counts
|
| 520 |
|
|
|a OBJECTIVE: The aim of this study was to modulate hematopoiesis in rats in vivo either through pharmacologic treatment or serial phlebotomy, and to determine whether the Sysmex XT-2000iV could accurately analyze bone marrow quantitative changes when compared with results obtained by microscopy
|
| 520 |
|
|
|a METHODS: Rats were treated once with 0, 5, 20, and 40 mg/kg cyclophosphamide (CP), 0, 50, 100 IU/kg erythropoietin (EPO) on 4 consecutive days, or serial phlebotomy of 1-2 mL of blood for 4 days. Modulation of hematopoietic populations in bone marrow was evaluated using the Sysmex XT-2000iV hematology analyzer, and compared with microscopic differential counts
|
| 520 |
|
|
|a RESULTS: Correlation coefficients between M:E ratios determined by Sysmex and the microscopic method were 0.94, 0.96, and 0.98 for CP, EPO, or serial phlebotomy treatments, respectively. Mean concordance correlation coefficients for M:E demonstrated method agreement of 0.63, 0.92, and 0.85 for the 3 treatments. Quantitative automated and microscopic bone marrow differential counts were within the expected 95% confidence intervals for CP, EPO or serial phlebotomy
|
| 520 |
|
|
|a CONCLUSIONS: The Sysmex XT-2000iV provides quantitative bone marrow differential counts of bone marrow cell series in rats with treatment-induced changes which are comparable to microscopic differential counts. Reliable automatic bone marrow differential counting allows increased throughput, sensitivity, reproducibility, and enhanced interpretation of bone marrow evaluation in rodent preclinical studies
|
| 650 |
|
4 |
|a Comparative Study
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Cytology
|
| 650 |
|
4 |
|a flow cytometry
|
| 650 |
|
4 |
|a hematotoxicity
|
| 650 |
|
4 |
|a preclinical safety
|
| 650 |
|
7 |
|a Immunosuppressive Agents
|2 NLM
|
| 650 |
|
7 |
|a Erythropoietin
|2 NLM
|
| 650 |
|
7 |
|a 11096-26-7
|2 NLM
|
| 650 |
|
7 |
|a Cyclophosphamide
|2 NLM
|
| 650 |
|
7 |
|a 8N3DW7272P
|2 NLM
|
| 700 |
1 |
|
|a Bock, Jeffrey H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wildeboer, Samantha E
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Johnson, Kjell
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Giovanelli, Richard P
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Veterinary clinical pathology
|d 1975
|g 43(2014), 2 vom: 23. Juni, Seite 137-53
|w (DE-627)NLM098159984
|x 1939-165X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:43
|g year:2014
|g number:2
|g day:23
|g month:06
|g pages:137-53
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1111/vcp.12149
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 43
|j 2014
|e 2
|b 23
|c 06
|h 137-53
|